Diseases & Disorders
(G97Z)
990 on File
AMERICAN SOCIETY FOR COLPOSCOPY & CERVICAL PATHOLOGY
Financial strength (30%)
94/100
Reliability (20%)
55/100
Effectiveness (25%)
71/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$2.9M
Total Revenue
$2.6M
Total Expenses
$8.7M
Net Assets
9
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
74.4%
Fundraising Efficiency
N/A
Operating Reserve
40.56x
Liability-to-Asset
7.1%
Revenue Diversification
79.4%
Executive Compensation
$387K
Compared with Peers
FY 2025
Compared with 264 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
74.4% | 83.2% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
25.6% | 11.0% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 2.5% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
40.6 mo | 12.5 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
7.1% | 12.5% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
79.4% | 87.6% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
13.3% | 7.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
11.4% | 5.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
10.5% | 4.1% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $2.9M | $2.6M | $8.7M | 74.4% | 9 |
| 2024 | $2.5M | $2.3M | $8.0M | 75.2% | 12 |
| 2023 | $2.4M | $2.2M | $6.5M | 76.2% | 8 |
| 2022 | $2.6M | $1.8M | $5.9M | 76.7% | 6 |
| 2021 | $2.2M | $1.2M | N/A | — | 5 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.